药物输送
医学
靶向给药
药品
计算生物学
药理学
生物
化学
有机化学
作者
A Amruta,Dalila Iannotta,Seth W. Cheetham,Twan Lammers,Joy Wolfram
标识
DOI:10.1016/j.addr.2023.115054
摘要
Over the past decades, there has been an exponential increase in the development of preclinical and clinical nanodelivery systems, and recently, an accelerating demand to deliver RNA and protein-based therapeutics. Organ-specific vasculature provides a promising intermediary for site-specific delivery of nanoparticles and extracellular vesicles to interstitial cells. Endothelial cells express organ-specific surface marker repertoires that can be used for targeted delivery. This article highlights organ-specific vasculature properties, nanodelivery strategies that exploit vasculature organotropism, and overlooked challenges and opportunities in targeting and simultaneously overcoming the endothelial barrier. Impediments in the clinical translation of vasculature organotropism in drug delivery are also discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI